On Tuesday, health insurers sold off on the Centers for Medicare & Medicaid Services' proposed CRUSH anti-fraud rule, and their options barely reacted. On Wednesday, November 18, 2026, the selling got heavier, and this time the options market did react.

Day Two Was Worse Than Day One

Want to apply this to your own portfolio?Open OptionsPilot →

StreetInsider and Investing.com said the decline continued Wednesday because of the CRUSH proposal. It would codify risk adjustment data validation (RADV) audits of Medicare Advantage plans without a fee-for-service adjuster and apply findings back to payment year 2018. Both reports said CMS puts the recovery at about $9 billion per payment year industrywide. Both also noted that Senator Elizabeth Warren called for breaking up vertically integrated health companies, naming UnitedHealth, CVS and Cigna, and pointed to the Break Up Big Medicine Act. The HHS announcement describes the rule as saving nearly $90 billion over 10 years. It is still a proposal.

UnitedHealth runs the largest Medicare Advantage business in the country, and its stock fell the most among large insurers. The figures below are Cboe's 15-minute-delayed quotes as of about 11:50 a.m. Eastern:

| Stock | Tuesday close | Wednesday low | Late morning | Change | IV30 (change) | UnitedHealth (UNH)$389.68$358.33~$358.62~−8.0%~42.6 (+6.9) Humana (HUM)$443.34$401.97~$408.50~−7.9%~49.6 (+4.7) Elevance (ELV)$433.93$405.96~$408.04~−6.0%~34.1 (+2.3) CVS Health (CVS)$85.81$82.34~$82.75~−3.6%~33.7 (+3.0) Cigna (CI)$294.06$284.33~$286.03~−2.7%~29.1 (+1.1)

UNH opened near $387 and fell steadily into late morning, trading close to its low of the day. From Monday's $412.02 close, it is down about 13% in two sessions. Humana is down about 11% over the same stretch, from $461.25.

The IV Jump Tuesday Didn't Have

In our Tuesday article, managed-care 30-day implied volatility rose only 1 to 2 points while the stocks fell 2% to 6%. Our reasoning was that a proposed rule takes months or years to play out, so a weekly option has little reason to price it. Wednesday's chain disagrees, at least in part. UNH's IV30 rose about 6.9 points to 42.6, roughly a 19% jump in one day, and Humana's rose about 4.7 points.

A second straight day of selling in a mega-cap is itself something options price, whatever the rule's timeline. Sellers of premium often widen quotes and raise IV when a stock keeps setting new lows, because the next day's range looks less predictable.

Tuesday's Straddle Buyer Is Well Past the Break-Even

At Tuesday's late-morning quotes, the Nov. 20 $397.50 straddle was about $13.50, which put its lower break-even near $384. UNH is now about $25 below that. This is our arithmetic, not a forecast. Here is the new at-the-money $360 strike at quote midpoints:

Expiration$360 straddle (mid)Share of stock priceATM IV, approx. Nov 20~$14.03~3.9%~63% Nov 27~$20.23~5.6%~44% | Dec 18 | ~$35.10 | ~9.8% | ~42% |

Friday's options now price roughly another $14 move in two and a half sessions, more than Tuesday's straddle priced for the whole week. The front of the curve is the most expensive. Friday's IV is about 20 points above December's, which is how a chain looks when traders expect most of the near-term risk to come in the next few days.

Puts Took Over the Tape

On Tuesday, UNH volume leaned toward calls. By late morning Wednesday it had flipped: about 45,100 puts against 31,900 calls. The busiest lines:

  • Mar 19, 2027 $390 put: about 4,000 contracts, open interest about 5,170
  • Mar 19, 2027 $360 put: about 3,790 contracts, above its open interest of about 2,060, a sign of new positions
  • Nov 20 $360 put: about 3,580 contracts, open interest about 3,520
  • Nov 20 $350 put: about 2,100 contracts, open interest about 7,680
  • Nov 20 $365 put: about 2,040 contracts, almost three times its open interest of about 690
  • The Jan. 15, 2027 $450 call, Tuesday's busiest line, traded about 1,450 more contracts and was quoted near $1.56 to $1.74. Volume alone doesn't show whether puts were bought or sold. Some of this is probably hedging of existing shares or rolling of older positions, and some may be bearish bets.

    Before Selling the Spike or Buying the Bounce

  • Headline risk hasn't gone away. The comment period, a revised or withdrawn rule, a court ruling on the earlier RADV rule or new political news could each move these stocks sharply in either direction.
  • Expensive premium cuts both ways. Puts bought at around 63% IV need a big further drop to pay off by Friday. Short puts or short straddles collect that premium but can lose far more than they collect if the slide continues.
  • Assignment is large. A short $360 put that ends in the money can be assigned, which means buying 100 shares for $36,000 per contract.
  • Sector correlation. UNH, HUM, ELV and CVS moved together two days in a row. Positions across several of them can carry more combined risk than they appear to.
  • Defined risk. Spreads such as credit spreads cap the maximum loss, but they also cap the gain.
  • For background, see our implied volatility explainer and the OCC options disclosure document.

    Sources

  • Cboe: UNH delayed quotes and option chain
  • HHS: CMS CRUSH proposed rule (Nov. 16, 2026)
  • StreetInsider: UnitedHealth stock continues lower amid federal audit proposal
  • Investing.com: Why is UnitedHealth stock sliding today?
  • Yahoo Finance: Stock market today, Wednesday, November 18
  • OCC: Characteristics and Risks of Standardized Options
  • *By the OptionsPilot Editorial Team. Published November 18, 2026, 9:25 AM PT. Stock and option prices are 15-minute-delayed Cboe quotes as of about 11:48 to 11:54 a.m. Eastern, at quote midpoints unless noted. Tuesday option prices are from our November 17 late-morning snapshot. All will change during the session. This article is for education only and is not investment advice. Options involve risk and are not suitable for all investors.*